Showing results (131-140 of 369) with videos related to
Sort By:
Pageof 37
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|January 22, 2002
Combined 18F-FDG and 11C-methionine PET scans in patients with newly progressive metastatic prostate cancerRodolfo Nuñez, Homer A Macapinlac, Henry W D Yeung, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 12, 2009
Fluorescence in situ hybridization analysis of circulating tumor cells in metastatic prostate cancerMargaret A Leversha, Jialian Han, Zahra Asgari, et al.European Urology|July 15, 2014
Impact of baseline corticosteroids on survival and steroid androgens in metastatic castration-resistant prostate cancer: exploratory analysis from COU-AA-301Bruce Montgomery, Thian Kheoh, Arturo Molina, et al.Scientific Reports|July 1, 2016
Small Glutamine-Rich Tetratricopeptide Repeat-Containing Protein Alpha (SGTA) Ablation Limits Offspring Viability and Growth in MiceLisa K Philp, Tanya K Day, Miriam S Butler, et al.European Urology|April 21, 2009
Phase 1 trial of high-dose exogenous testosterone in patients with castration-resistant metastatic prostate cancerMichael J Morris, Daisy Huang, William K Kelly, et al.Molecular Cancer Therapeutics|January 16, 2007
Suberoylanilide hydroxamic acid (vorinostat) represses androgen receptor expression and acts synergistically with an androgen receptor antagonist to inhibit prostate cancer cell proliferationDeborah L Marrocco, Wayne D Tilley, Tina Bianco-Miotto, et al.Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|June 17, 2008
Antibody mass escalation study in patients with castration-resistant prostate cancer using 111In-J591: lesion detectability and dosimetric projections for 90Y radioimmunotherapyNeeta Pandit-Taskar, Joseph A O'Donoghue, Michael J Morris, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 1, 2007
Long-term toxicity monitoring via electronic patient-reported outcomes in patients receiving chemotherapyEthan Basch, Alexia Iasonos, Allison Barz, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 7, 2007
Circulating tumor cell number and prognosis in progressive castration-resistant prostate cancerDaniel C Danila, Glenn Heller, Gretchen A Gignac, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 4, 2007
Evaluation of plasma insulin-like growth factor binding protein 2 and Her-2 extracellular domain as biomarkers for 17-allylamino-17-demethoxygeldanamycin treatment of adult patients with advanced solid tumorsJulie L Eiseman, Jianxia Guo, Ramesh K Ramanathan, et al.Pageof 37